Home » Newsletters » BioWorld Science

BioWorld Science

May 23, 2018

View Archived Issues

Phase I data presented for iCasp9M28z CAR T cells in pleural cancer

Acceleron initiates phase II PULSAR study of sotatercept in pulmonary arterial hypertension

Hemlibra subcutaneous injection now available in Japan

Sublimity Therapeutics closes financing to fund development of STI-0529 in ulcerative colitis

Allergan to acquire AGN-241751 from Aptinyx discovery platform

First patient enrolled in phase II study of MABp1 in atopic dermatitis

FDA clears IND application for CX-2029

FDA approves Arnuity Ellipta as prophylactic therapy of asthma in children aged 5 to 11 years

Rigel Pharmaceuticals presents IRAK-1 inhibitors

Nuclear receptor ROR-gamma inverse agonists disclosed by Escalier Biosciences

Vast Therapeutics' BIOC-51 eradicates NTM in animal model

Actavalon discovers anticancer compounds

Cognition Therapeutics awarded NIH grants to further study lead candidate

Monoclonal antibodies shown to protect mice from EBOV infection

Biguanide derivative shows promise for prostate cancer therapy

Arbutus Biopharma, Protiva Biotherapeutics patent anti-HBV compounds

Roche describes compounds for hepatitis B virus infection

Sphingosine 1-phosphate receptor 5 agonists identified at AbbVie

University of Wollongong presents u-PA inhibitors

Kyowa Hakko Kirin launches Orkedia in Japan

New phase IIb study explores use of cytomegalovirus vaccine V-160

Angiocrine initiates phase Ib study of AB-110 in hematologic malignancies

Pfizer studies PF-06763809 in phase I trial for chronic plaque psoriasis

VFMCRP and Cara sign development and commercialization agreement for CR-845

First phase IIa data for Yungjin Pharmaceutical's YPL-001 in COPD

Sujanu launched in Japan

FDA advisory committee recommends against approval of Insys' buprenorphine sublingual spray

Rhinovirus vaccine uses capsid proteins to generate neutralizing antibodies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...